Lynne Powell
Director/Board Member at BIORA THERAPEUTICS, INC.
Net worth: 3 488 $ as of 30/04/2024
Profile
Lynne M.
Powell is currently the Chief Executive Officer & Director at Tavanta Therapeutics, Inc. and an Independent Director at Biora Therapeutics, Inc. She was previously the Chief Executive Officer & Director at Druggability Technologies Holdings Ltd., Chief Commercial Officer & Senior Vice President at BioCryst Pharmaceuticals, Inc., and Senior VP-North American Commercial Operations at CSL Behring LLC.
Powell holds an MBA from Monash University and the University of Warwick, and an undergraduate degree from the University of East London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIORA THERAPEUTICS, INC.
0.02% | 01/03/2024 | 5,746 ( 0.02% ) | 3 488 $ | 30/04/2024 |
Lynne Powell active positions
| Companies | Position | Start |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Director/Board Member | 01/02/2019 |
Tavanta Therapeutics, Inc.
 Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tavanta Therapeutics, Inc. operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs. The company is based in King of Prussia, PA and has subsidiaries in Hungary. Lynne M. Powell has been the CEO of the company since 2019. | Chief Executive Officer | 01/09/2019 |
Former positions of Lynne Powell
| Companies | Position | End |
|---|---|---|
Druggability Technologies Holdings Ltd.
 Druggability Technologies Holdings Ltd. BiotechnologyHealth Technology Druggability Technologies Holdings Ltd., part of DRGT Holdco (Malta) Ltd., is a company headquartered in Dublin, Ireland. The firm develops proprietary drugs. | Chief Executive Officer | 01/10/2019 |
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2019 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | 01/10/2014 |
Training of Lynne Powell
| Monash University | Masters Business Admin |
| University of Warwick | Masters Business Admin |
| University of East London | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Private companies | 3 |
|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Druggability Technologies Holdings Ltd.
Druggability Technologies Holdings Ltd. BiotechnologyHealth Technology Druggability Technologies Holdings Ltd., part of DRGT Holdco (Malta) Ltd., is a company headquartered in Dublin, Ireland. The firm develops proprietary drugs. | Health Technology |
Tavanta Therapeutics, Inc.
Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tavanta Therapeutics, Inc. operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs. The company is based in King of Prussia, PA and has subsidiaries in Hungary. Lynne M. Powell has been the CEO of the company since 2019. | Health Technology |
- Stock Market
- Insiders
- Lynne Powell
